With respect to the antioxidant enzymes activities, the subjects with MS had lower CAT (P = 0.02), SOD (P < 0.01), and GPx activities (P < 0.01) than those in the non-MS group. This evidence concerns the gene SOD1 and myeloid sarcoma.